Biomet: Market Segment Forecasts and Company Strategic Assessment
A strategic assessment of Biomet, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.
Contains 35 pages
Contains 35 pages
SECTION 1: BUSINESS EVOLUTION AND ORGANIZATION
SECTION 2: TECHNOLOGICAL KNOW-HOW
SECTION 3: PRODUCT PORTFOLIO
SECTION 4: MARKETING TACTICS
SECTION 5: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 6: STRATEGIC DIRECTION
SECTION 2: TECHNOLOGICAL KNOW-HOW
SECTION 3: PRODUCT PORTFOLIO
SECTION 4: MARKETING TACTICS
SECTION 5: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 6: STRATEGIC DIRECTION
More Publications
Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
US$ 27,800.00
December 2016
1200 pages
2016-2020 Japan Respiratory Diseases Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
US$ 1,920.00
March 2016
282 pages
Global Infectious Disease Testing Market for 100 Tests: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities
US$ 27,500.00
November 2019
1954 pages
Specialty Chemicals: Marketing Tactics of Leading Suppliers
US$ 1,960.00
July 2016
35 pages
